CDC Supporting Response to New Ebola Outbreak in North Kivu

Article

The Centers for Disease Control and Prevention (CDC) has been responding and coordinating with the Ministry of Health of the Democratic Republic of the Congo (DRC) since a new outbreak of Ebola in North Kivu province was reported on July 30, 2018. Early response is critical to contain any viral hemorrhagic fever (VHF) outbreaks, but it is especially difficult in remote and resource-challenged areas. For the current outbreak, CDC has deployed experienced Ebola experts to DRC and the World Health Organization to provide guidance on coordination of outbreak response, laboratory testing, disease contact tracing, infection control, and health communication.

Genetic sequencing tests performed at DRC’s national laboratory shows the ebolavirus species associated with the current outbreak is ebolavirus Zaire, the same species that caused an outbreak earlier this year in Equateur province in northwestern DRC. However, differences between the genes of the viruses suggest the two outbreaks are not linked.

The CDC will provide additional support as needed to enhance disease tracking, laboratory testing, and developing guidance and tools to conduct public health investigations and implementation of ring vaccination. This work includes tracing people who have been in contact with cases, providing infection control recommendations, supporting vaccination of people at risk, and giving the latest information to the general public, healthcare workers, international travelers, and public health partners.

The CDC also has issued a travel notice; there is no recommendation to avoid travel to DRC. Travelers are advised to avoid infected people’s blood and body fluids.

Source: CDC

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
Bug of the Month
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.